{"entity":{"type":"insider","cik":"0001652973","url":"/insider/0001652973","json_url":"/insider/0001652973.json","name":"Leuthner Brian A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":36,"n_filings":18,"first":"2016-08-02","last":"2021-06-29","span_basis":"filed_date"},"name_variants":[{"name":"Leuthner Brian A","source":"filing","n_filings":18,"first_seen":"2016-08-02","last_seen":"2021-06-29"}],"transactions":[{"id":5071451,"accession":"0001493152-21-015620","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-21-015620","line_url":"/filing/0001493152-21-015620#line-2","is_derivative":false,"issuer_cik":"0001444307","issuer_name":"ONCOSEC MEDICAL Inc","issuer_ticker":"ONCS","issuer_name_source":null,"issuer_url":"/issuer/0001444307","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Officer (Interim CEO)","role_mark":"O","role_mark_label":"Officer (Interim CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13613.0,"shares_display":"13,613","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":43017.08,"total_display":"43,017.08","total_whole":"43,017","shares_owned_after":178387.0,"shares_owned_after_display":"178,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-29","scope":"insider"},{"id":6261755,"accession":"0001127602-18-009804","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-009804","line_url":"/filing/0001127602-18-009804#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":15.08,"price_display":"15.08","price_state":"stated","total_value":37700.0,"total_display":"37,700.00","total_whole":"37,700","shares_owned_after":70236.0,"shares_owned_after_display":"70,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-02","filed_date":"2018-03-05","scope":"insider"},{"id":6261750,"accession":"0001127602-18-009804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-18-009804","line_url":"/filing/0001127602-18-009804#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":14.81,"price_display":"14.81","price_state":"stated","total_value":37025.0,"total_display":"37,025.00","total_whole":"37,025","shares_owned_after":72736.0,"shares_owned_after_display":"72,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-05","scope":"insider"},{"id":6222310,"accession":"0001127602-18-008091","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-008091","line_url":"/filing/0001127602-18-008091#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":15.37,"price_display":"15.37","price_state":"stated","total_value":38425.0,"total_display":"38,425.00","total_whole":"38,425","shares_owned_after":75236.0,"shares_owned_after_display":"75,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-23","filed_date":"2018-02-23","scope":"insider"},{"id":6222306,"accession":"0001127602-18-008091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-18-008091","line_url":"/filing/0001127602-18-008091#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":15.47,"price_display":"15.47","price_state":"stated","total_value":38675.0,"total_display":"38,675.00","total_whole":"38,675","shares_owned_after":77736.0,"shares_owned_after_display":"77,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-22","filed_date":"2018-02-23","scope":"insider"},{"id":6606182,"accession":"0001127602-18-003874","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-003874","line_url":"/filing/0001127602-18-003874#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":12.96,"price_display":"12.96","price_state":"stated","total_value":32400.0,"total_display":"32,400.00","total_whole":"32,400","shares_owned_after":80236.0,"shares_owned_after_display":"80,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-02","filed_date":"2018-02-02","scope":"insider"},{"id":6606179,"accession":"0001127602-18-003874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-18-003874","line_url":"/filing/0001127602-18-003874#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":13.14,"price_display":"13.14","price_state":"stated","total_value":32850.0,"total_display":"32,850.00","total_whole":"32,850","shares_owned_after":82736.0,"shares_owned_after_display":"82,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-02","scope":"insider"},{"id":6044310,"accession":"0001127602-18-000813","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-18-000813","line_url":"/filing/0001127602-18-000813#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.11,"price_display":"10.11","price_state":"stated","total_value":25275.0,"total_display":"25,275.00","total_whole":"25,275","shares_owned_after":85236.0,"shares_owned_after_display":"85,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-03","filed_date":"2018-01-03","scope":"insider"},{"id":6044307,"accession":"0001127602-18-000813","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-18-000813","line_url":"/filing/0001127602-18-000813#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.11,"price_display":"10.11","price_state":"stated","total_value":25275.0,"total_display":"25,275.00","total_whole":"25,275","shares_owned_after":87736.0,"shares_owned_after_display":"87,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-03","scope":"insider"},{"id":4235073,"accession":"0001127602-17-033971","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-17-033971","line_url":"/filing/0001127602-17-033971#line-3","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":9.68,"price_display":"9.68","price_state":"stated","total_value":24200.0,"total_display":"24,200.00","total_whole":"24,200","shares_owned_after":90236.0,"shares_owned_after_display":"90,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-05","filed_date":"2017-12-05","scope":"insider"},{"id":4235069,"accession":"0001127602-17-033971","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-17-033971","line_url":"/filing/0001127602-17-033971#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":9.97,"price_display":"9.97","price_state":"stated","total_value":24925.0,"total_display":"24,925.00","total_whole":"24,925","shares_owned_after":92736.0,"shares_owned_after_display":"92,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-04","filed_date":"2017-12-05","scope":"insider"},{"id":4235065,"accession":"0001127602-17-033971","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-033971","line_url":"/filing/0001127602-17-033971#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":9.92,"price_display":"9.92","price_state":"stated","total_value":24800.0,"total_display":"24,800.00","total_whole":"24,800","shares_owned_after":95236.0,"shares_owned_after_display":"95,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":4855821,"accession":"0001127602-17-031249","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-17-031249","line_url":"/filing/0001127602-17-031249#line-3","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.86,"price_display":"10.86","price_state":"stated","total_value":27150.0,"total_display":"27,150.00","total_whole":"27,150","shares_owned_after":97736.0,"shares_owned_after_display":"97,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-03","filed_date":"2017-11-03","scope":"insider"},{"id":4855818,"accession":"0001127602-17-031249","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-17-031249","line_url":"/filing/0001127602-17-031249#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.94,"price_display":"10.94","price_state":"stated","total_value":27350.0,"total_display":"27,350.00","total_whole":"27,350","shares_owned_after":100236.0,"shares_owned_after_display":"100,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-02","filed_date":"2017-11-03","scope":"insider"},{"id":4855813,"accession":"0001127602-17-031249","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-031249","line_url":"/filing/0001127602-17-031249#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":27300.0,"total_display":"27,300.00","total_whole":"27,300","shares_owned_after":102736.0,"shares_owned_after_display":"102,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-01","filed_date":"2017-11-03","scope":"insider"},{"id":4170540,"accession":"0001127602-17-029259","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-17-029259","line_url":"/filing/0001127602-17-029259#line-3","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":11.14,"price_display":"11.14","price_state":"stated","total_value":27850.0,"total_display":"27,850.00","total_whole":"27,850","shares_owned_after":105236.0,"shares_owned_after_display":"105,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-04","filed_date":"2017-10-04","scope":"insider"},{"id":4170531,"accession":"0001127602-17-029259","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-17-029259","line_url":"/filing/0001127602-17-029259#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.93,"price_display":"10.93","price_state":"stated","total_value":27325.0,"total_display":"27,325.00","total_whole":"27,325","shares_owned_after":107736.0,"shares_owned_after_display":"107,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-03","filed_date":"2017-10-04","scope":"insider"},{"id":4170524,"accession":"0001127602-17-029259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-029259","line_url":"/filing/0001127602-17-029259#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.81,"price_display":"10.81","price_state":"stated","total_value":27025.0,"total_display":"27,025.00","total_whole":"27,025","shares_owned_after":110236.0,"shares_owned_after_display":"110,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":4532346,"accession":"0001127602-17-027107","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-17-027107","line_url":"/filing/0001127602-17-027107#line-3","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.31,"price_display":"10.31","price_state":"stated","total_value":25775.0,"total_display":"25,775.00","total_whole":"25,775","shares_owned_after":112736.0,"shares_owned_after_display":"112,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-06","filed_date":"2017-09-06","scope":"insider"},{"id":4532341,"accession":"0001127602-17-027107","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-17-027107","line_url":"/filing/0001127602-17-027107#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":9.94,"price_display":"9.94","price_state":"stated","total_value":24850.0,"total_display":"24,850.00","total_whole":"24,850","shares_owned_after":115236.0,"shares_owned_after_display":"115,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-05","filed_date":"2017-09-06","scope":"insider"},{"id":4532336,"accession":"0001127602-17-027107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-027107","line_url":"/filing/0001127602-17-027107#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.37,"price_display":"10.37","price_state":"stated","total_value":25925.0,"total_display":"25,925.00","total_whole":"25,925","shares_owned_after":117736.0,"shares_owned_after_display":"117,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-01","filed_date":"2017-09-06","scope":"insider"},{"id":5215192,"accession":"0001127602-17-024929","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-17-024929","line_url":"/filing/0001127602-17-024929#line-3","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.4,"price_display":"10.40","price_state":"stated","total_value":26000.0,"total_display":"26,000.00","total_whole":"26,000","shares_owned_after":120236.0,"shares_owned_after_display":"120,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-03","filed_date":"2017-08-03","scope":"insider"},{"id":5215187,"accession":"0001127602-17-024929","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-17-024929","line_url":"/filing/0001127602-17-024929#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.53,"price_display":"10.53","price_state":"stated","total_value":26325.0,"total_display":"26,325.00","total_whole":"26,325","shares_owned_after":122736.0,"shares_owned_after_display":"122,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-02","filed_date":"2017-08-03","scope":"insider"},{"id":5215182,"accession":"0001127602-17-024929","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-024929","line_url":"/filing/0001127602-17-024929#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.65,"price_display":"10.65","price_state":"stated","total_value":26625.0,"total_display":"26,625.00","total_whole":"26,625","shares_owned_after":125236.0,"shares_owned_after_display":"125,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-01","filed_date":"2017-08-03","scope":"insider"},{"id":5065647,"accession":"0001127602-17-023286","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-17-023286","line_url":"/filing/0001127602-17-023286#line-3","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.08,"price_display":"10.08","price_state":"stated","total_value":25200.0,"total_display":"25,200.00","total_whole":"25,200","shares_owned_after":127736.0,"shares_owned_after_display":"127,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-06","filed_date":"2017-07-06","scope":"insider"},{"id":5065641,"accession":"0001127602-17-023286","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-17-023286","line_url":"/filing/0001127602-17-023286#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.21,"price_display":"10.21","price_state":"stated","total_value":25525.0,"total_display":"25,525.00","total_whole":"25,525","shares_owned_after":130236.0,"shares_owned_after_display":"130,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-05","filed_date":"2017-07-06","scope":"insider"},{"id":5065634,"accession":"0001127602-17-023286","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-023286","line_url":"/filing/0001127602-17-023286#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":10.27,"price_display":"10.27","price_state":"stated","total_value":25675.0,"total_display":"25,675.00","total_whole":"25,675","shares_owned_after":132736.0,"shares_owned_after_display":"132,736","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-03","filed_date":"2017-07-06","scope":"insider"},{"id":4699556,"accession":"0001127602-17-017360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-017360","line_url":"/filing/0001127602-17-017360#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":11.1,"price_display":"11.10","price_state":"stated","total_value":1110.0,"total_display":"1,110.00","total_whole":"1,110","shares_owned_after":135236.0,"shares_owned_after_display":"135,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-26","filed_date":"2017-05-09","scope":"insider"},{"id":4852701,"accession":"0001127602-17-004564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-004564","line_url":"/filing/0001127602-17-004564#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":9.52,"price_display":"9.52","price_state":"stated","total_value":14280.0,"total_display":"14,280.00","total_whole":"14,280","shares_owned_after":245479.0,"shares_owned_after_display":"245,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-07","filed_date":"2017-02-08","scope":"insider"},{"id":4490703,"accession":"0001127602-17-004341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-17-004341","line_url":"/filing/0001127602-17-004341#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":9.52,"price_display":"9.52","price_state":"stated","total_value":14280.0,"total_display":"14,280.00","total_whole":"14,280","shares_owned_after":246979.0,"shares_owned_after_display":"246,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-06","filed_date":"2017-02-07","scope":"insider"},{"id":4490700,"accession":"0001127602-17-004341","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-004341","line_url":"/filing/0001127602-17-004341#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":9.69,"price_display":"9.69","price_state":"stated","total_value":14535.0,"total_display":"14,535.00","total_whole":"14,535","shares_owned_after":248479.0,"shares_owned_after_display":"248,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-03","filed_date":"2017-02-07","scope":"insider"},{"id":4936043,"accession":"0001127602-17-003847","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-17-003847","line_url":"/filing/0001127602-17-003847#line-2","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":9.61,"price_display":"9.61","price_state":"stated","total_value":14415.0,"total_display":"14,415.00","total_whole":"14,415","shares_owned_after":249979.0,"shares_owned_after_display":"249,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-02","filed_date":"2017-02-03","scope":"insider"},{"id":4936037,"accession":"0001127602-17-003847","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-17-003847","line_url":"/filing/0001127602-17-003847#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":9.38,"price_display":"9.38","price_state":"stated","total_value":14070.0,"total_display":"14,070.00","total_whole":"14,070","shares_owned_after":251479.0,"shares_owned_after_display":"251,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-01","filed_date":"2017-02-03","scope":"insider"},{"id":2214542,"accession":"0001127602-16-068954","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-16-068954","line_url":"/filing/0001127602-16-068954#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":11.6,"price_display":"11.60","price_state":"stated","total_value":87000.0,"total_display":"87,000.00","total_whole":"87,000","shares_owned_after":252979.0,"shares_owned_after_display":"252,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-02","scope":"insider"},{"id":3328994,"accession":"0001127602-16-063859","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-16-063859","line_url":"/filing/0001127602-16-063859#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":10.2459,"price_display":"10.25","price_state":"stated","total_value":76844.25,"total_display":"76,844.25","total_whole":"76,844","shares_owned_after":260479.0,"shares_owned_after_display":"260,479","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-04","scope":"insider"},{"id":2600054,"accession":"0001127602-16-059215","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-16-059215","line_url":"/filing/0001127602-16-059215#line-1","is_derivative":false,"issuer_cik":"0001472091","issuer_name":"Edge Therapeutics, Inc.","issuer_ticker":"EDGE","issuer_name_source":null,"issuer_url":"/issuer/0001472091","owner_cik":"0001652973","owner_name":"Leuthner Brian A","owner_display_name":"Leuthner Brian A","owner_url":"/insider/0001652973","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":9.5442,"price_display":"9.54","price_state":"stated","total_value":71581.5,"total_display":"71,581.50","total_whole":"71,582","shares_owned_after":267979.0,"shares_owned_after_display":"267,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":36,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":36,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":36},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001444307","name":"ONCOSEC MEDICAL Inc","url":"/issuer/0001444307","role":"Officer (Interim CEO)","n_filings":1,"first_seen":"2021-06-29","last_seen":"2021-06-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001472091","name":"Edge Therapeutics, Inc.","url":"/issuer/0001472091","role":"Director, Officer (President and CEO)","n_filings":17,"first_seen":"2016-08-02","last_seen":"2018-03-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001652973","retrieved_at":"2026-08-23T21:21:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}